Isabel Lemos
Lisbon, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Dissecting Cancer Metabolism and Therapeutic Resistance Using In Vitro Platforms.
Journal: Advances in experimental medicine and biology
Published: July 11, 2026
Cell-Free DNA (cfDNA), Its Applications in Cancer Diagnosis and Monitoring, and Its Potential Role in Regulating Cancer Metabolism.
Journal: Advances in experimental medicine and biology
Published: July 11, 2026
Glucagon and Glucose Availability Influence Metabolic Heterogeneity and Malignancy in Pancreatic Neuroendocrine Tumour (pNET) Cells: Novel Routes for Therapeutic Targeting.
Journal: Molecules (Basel, Switzerland)
Published: May 07, 2025
Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling, Sustaining Proliferation, Quiescence, and Migration in MDA-MB-231, a Triple-Negative Breast Carcinoma (TNBC) Cell Line.
Journal: Metabolites
Published: February 25, 2025
Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cells.
Journal: Bioscience reports
Published: June 12, 2024
Interaction between NSCLC Cells, CD8+ T-Cells and Immune Checkpoint Inhibitors Potentiates Coagulation and Promotes Metabolic Remodeling-New Cues on CAT-VTE.
Journal: Cells
Published: January 03, 2024
H2S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized Medicine.
Journal: Antioxidants (Basel, Switzerland)
Published: December 05, 2023
BRD9 status is a major contributor for cysteine metabolic remodeling through MST and EAAT3 modulation in malignant melanoma.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: June 06, 2023
NSCLC presents metabolic heterogeneity, and there is still some leeway for EGF stimuli in EGFR-mutated NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 20, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026